Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.

This phase 2 trial assessed the combination of transarterial chemoembolization (TACE) with atezolizumab and bevacizumab...

Continue ReadingTransarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.

Population frequency of Predicted pathogenic MisMatch Repair (MMR) gene variants in Lynch syndrome from bioinformatic analyses of the general population.

This study reevaluated the population frequency of Lynch syndrome by analyzing predicted pathogenic variants in mismatch...

Continue ReadingPopulation frequency of Predicted pathogenic MisMatch Repair (MMR) gene variants in Lynch syndrome from bioinformatic analyses of the general population.